Lily Zou, PhD, MBA
Board Member, Membership Committee Member, BioKatalyst
CEO, Fosun Pharma USA
Lily is the CEO of Fosun Pharma USA, who is responsible for Commercial Operations, BD and Investment Activities in the US.
Lily has extensive experience in BD/Investment, Strategy and Operations. Prior to Fosun pharma USA, her experiences include management consultant at Bain & Co., BD/M&A, Strategic planning and R&D Management at Novartis/Sandoz, Wyeth, Millennium, Coley and ArQule. Lily has led the negotiation and execution of over 40 product BD/investment deals, including innovative and generic products.
Lily received a B.S. from Peking University, PhD in Molecular Biology from Cornell University and an MBA from MIT.